July 12, 2023 by Chain Drug Review
and other diseases., COVID-19, Getting vaccinated can be a family affair. Rite Aid will offer Back to School Family Immunization Days at select stores, including Bartell Drugs in the Pacific Northwest, providing families convenient opportunities to walk in and get the vaccinations they need to protect themselves against measles, whooping cough
Leading Headlines, Retail News
PHILADELPHIA — Getting vaccinated can be a family affair. Rite Aid will offer Back to School Family Immunization Days at select stores, including Bartell Drugs in the Pacific Northwest, providing families convenient opportunities to walk in and get the vaccinations they need to protect themselves against measles, whooping cough, COVID-19, and other diseases. Rite Aid
August 12, 2022 by Chain Drug Review
CDC, COVID-19
Leading Headlines, Pharmacy
WASHINGTON — The Centers for Disease Control and Prevention has dropped its recommendation that Americans quarantine if they come in close contact with a person who has COVID-19. The CDC also said people no longer need to stay at least six feet away from others. Agency officials made these changes after estimating 95 % of
April 19, 2022 by Chain Drug Review
COVID-19, Former FDA Associate Commissioner Professor Peter Pitts, mask mandate
Leading Headlines, Pharmacy
NEW YORK — A federal judge in Florida struck down on Monday the Biden administration’s mask mandate for airplanes and other public transport methods. US District Judge Kathryn Kimball Mizelle said the mandate was unlawful because it exceeded the statutory authority of the US Centers for Disease Control and Prevention and because its implementation violated administrative law. Former FDA Associate
February 21, 2022 by Jeffrey Woldt
COVID-19, pharmacist, pharmacy
February 21, 2022, Opinion
The intense pressure that retail pharmacists face when they go to work — where high demand for COVID immunizations and tests is layered on top of an already formidable array of other duties — was the subject of a recent report on “PBS NewsHour.” The segment consisted of excerpts from interviews with five pharmacists who
January 13, 2022 by Chain Drug Review
COVID-19, President Biden
Leading Headlines
WASHINGTON — President Biden announced Thursday that the government will double to 1 billion the rapid, at-home COVID-19 tests to be distributed free to Americans, along with “high-quality masks,” as he highlighted his efforts to “surge” resources to help the country weather the spike in coronavirus cases. Biden also announced that starting next week 1,000
December 22, 2021 by Chain Drug Review
COVID-19, Walgreens
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens has issued the following statement on the COVID-19 surge: “As the nation experiences a surge in COVID-19 cases coinciding with the holidays, we are seeing unprecedented demand for related testing and vaccine services and products. We remain committed to offering convenient access to COVID-19 vaccinations and testing services and products that
October 18, 2021 by Chain Drug Review
COVID-19, molnupiravir, Pfizer-BioNTech COVID-19 vaccine
News, October 18, 2021
NEW YORK — In an effort to keep reining in the pandemic, the Biden administration will invest $1 billion to quadruple the national supply of at-home COVID-19 tests by December. In addition, it is expanding the number of free community-based test sites to 30,000 nationwide, including 20,000 in pharmacies. The White House’s announcement of the
October 4, 2021 by Jeffrey Woldt
COVID-19, CVS, Karen Lynch
October 4, 2021, Opinion
An article in a recent edition of The Wall Street Journal about challenges caused by a shortfall of workers at CVS Health missed the forest for the trees, focusing on problems at a few of its more than 10,000 drug stores, while giving short shrift to the extraordinary contributions that CVS — like other retail
October 4, 2021 by David Pinto
COVID-19, retail pharmacy
October 4, 2021, Opinion
As the year 2021 winds down, one story dominates, not only marking the current year as indelible, but taking its rightful, yet rueful, place as one the most memorable periods in any year, and indeed any decade. The event that has made 2021 so painfully memorable is of course COVID-19, among the most devastating and
September 20, 2021 by Jeffrey Woldt
COVID-19, Delta variant
Opinion, September 20, 2021
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.” So said British Prime Minister Winston Churchill in November 1942 after Allied forces defeated the Axis powers at El Alamein, dealing a decisive blow to their bid for control of North
September 10, 2021 by Chain Drug Review
Biden administration, COVID-19, FMI
Leading Headlines, Pharmacy
ARLINGTON, Va. — The Biden administration’s announcement of vaccine mandates for businesses raises serious questions for retailers and supplier companies, two trade associations said on Friday. “The announcement yesterday by President Biden of an employer mandate on vaccinations and testing for employees, including fines and penalties for businesses that fail to comply, raises a tremendous
September 9, 2021 by Chain Drug Review
Biden administration, COVID-19
Leading Headlines, Pharmacy
WASHINGTON — President Biden today unveiled an new six-part plan to combat COVID-19 as the highly transmissible Delta variant spreads and some 80 million eligible Americans remain unvaccinated. “We’ve been patient, but our patience is wearing thin,” he said in a speech from the White House, making clear that he blamed the unvaccinated for the
August 18, 2021 by Chain Drug Review
COVID-19, Walgreens
Leading Headlines, Pharmacy
DEERFIELD, Ill. — Walgreens and CVS have issued the following statements in support of COVID-19 vaccine booster doses: “Today, the Department of Health and Human Services (HHS) public health and medical experts released a joint statement on the plan to administer COVID-19 vaccine booster doses beginning in mid-September. As we have throughout the pandemic, we
August 12, 2021 by Chain Drug Review
COVID-19, FDA
Leading Headlines, Pharmacy
NEW YORK— According to published reports, the Food and Drug Administration is expected to approve COVID-19 vaccine booster shots this week. The FDA amendment of the emergency use authorizations for the Pfizer and Modern vaccines would allow anyone with compromised immune systems to get a third dose. The move, which could come as early as today, comes after